RUI: Combinatorial Synthesis of Protein-Polymer Conjugates by Post-Polymerization Modification of Side-Chain Reactive Polymers

非技术描述我们所知的生命如果没有蛋白质就不存在。蛋白质发挥着广泛的功能，如在体内输送氧气，识别和中和入侵的微生物。科学家们试图利用蛋白质精确而精致的功能来解决人类健康中的各种挑战，比如通过设计可以诊断和治疗疾病的蛋白质药物，或者通过设计新的蛋白质支架作为工程组织的一部分。最近，研究人员已经认识到通过用合成的分子修饰蛋白质来利用化学来增强或定制蛋白质功能的力量。例如，被称为聚合物的大分子可以通过化学键连接到蛋白质上，以增加蛋白质的稳定性，或者将药物分子捆绑在蛋白质上以创造更好的治疗方法。该项目的目标是开发一种将蛋白质与聚合物连接起来的全新方法。这种方法将提高制备蛋白质-聚合物偶联物(通过化学键连接到聚合物的蛋白质)的效率，用于包括药物输送在内的广泛应用。这项工作将使蛋白质-聚合物偶联物的结构可以轻松地根据特定应用的需要进行定制，而不必从头开始。最后，利用这种方法，可在人体内降解的聚合物结构可以偶联到蛋白质上，这对转化到临床上至关重要。为了证明这种方法的实用性，靶向癌细胞的蛋白质将被偶联到聚合物上，以开发新的治疗结构。首席调查员将与一群不同的本科生女性合作开展这项工作，以激励未来几代女性研究人员。此外，拟议的研究将在一个本科有机化学实验室进行，为更多的女性提供尖端研究机会。首席调查员还将邀请附近研究型大学的研究生和博士后学者合作教授本科生化学课程，作为一种手段，培训下一代大学教师在高等教育中的最佳教学实践。蛋白质-聚合物结合物将蛋白质的精致和精确的功能与合成聚合物的广泛功能结合在一起。这些生物结合物可用于应对生物技术和医学中的重要挑战，如疾病的诊断和治疗或设计新组织。蛋白质-聚合物偶联物通常是由蛋白质引发剂聚合而成，称为接枝，或通过将链端含有单一反应位点的聚合物偶联到蛋白质上的特定氨基酸上而合成，称为接枝。接枝形成要求单体是水溶性的，并与蛋白质结构相容；这些要求限制了可以并入结构的化学官能团的范围。由于需要两个大分子在一个位置反应，接枝到的偶联效率很低。在这两种方法中，每次需要新的生物共轭结构时都必须合成新的聚合物结构。这个NSF项目试图通过研究用于蛋白质-聚合物共轭化合物的模块化和组合合成的侧链反应性聚合物来直接解决这些限制。这项拟议的工作将使用聚合后修饰策略来合成亲水性的侧链反应性聚合物，这些聚合物可以通过胺活化的酯或硫醇-马来酰亚胺反应有效地连接到蛋白质上。侧链反应性聚合物和链端反应性聚合物将直接进行比较，以建立侧链反应性聚合物作为终端反应性聚合物的替代品。还将探索侧链反应性聚碳酸酯来合成可降解的蛋白质-聚合物偶联物。这里提出的工作将展示蛋白质-聚合物-药物结合物合成的有效组合路线，并有助于集体理解大分子结构如何影响蛋白质-聚合物结合物的功能。该奖项反映了NSF的法定使命，并通过使用基金会的智力优势和更广泛的影响审查标准进行评估，被认为值得支持。

Non-technical descriptionLife as we know it would not exist without proteins. Proteins perform functions as wide-ranging as transporting oxygen through the body to recognizing and neutralizing invading microorganisms. Scientists have sought to harness the precise and exquisite functions of proteins to solve a variety of challenges in human health, such as by designing protein drugs that can diagnose and treat disease or by designing new protein scaffolds as part of engineered tissues. Recently, researchers have recognized the power of using chemistry to augment or tailor the functions of proteins by modifying proteins with synthesized molecules. For example, large molecules known as polymers can be linked by chemical bonds to proteins in order to increase the stability of the protein or to tether drug molecules to the protein to create better therapeutics. The goal of this project is to develop a fundamentally new approach for linking proteins to polymers. This approach will improve the efficiency of preparing protein-polymer conjugates (proteins linked to polymers through chemical bonds) for a wide range of applications, including drug delivery. The work will allow the structures of the protein-polymer conjugates to be easily tailored to the needs of specific applications without having to start from scratch. Finally, polymer structures that are degradable in the human body can be coupled to proteins using this method, which is critical for translation to the clinic. To demonstrate the utility of this method, proteins that target cancer cells will be coupled to polymers for the development of new therapeutic structures. The principle investigator will conduct this work in collaboration with a diverse group of undergraduate women to inspire future generations of women researchers. Further, the proposed research will be conducted in an undergraduate organic chemistry laboratory to offer cutting-edge research opportunities to a larger population of women. The principle investigator will also invite graduate students and postdoctoral scholars from nearby research universities to work together to teach undergraduate chemistry courses as a means to train the next generation of college faculty in best pedagogical practices in higher education. Technical descriptionProtein-polymer conjugates couple the exquisite and precise functions of proteins with the wide-ranging functionality of synthetic polymers. These bioconjugates can be used to address important challenges in biotechnology and medicine such as the diagnosis and treatment of disease or engineering new tissues. Protein-polymer conjugates are generally synthesized by polymerizing monomers from protein initiators, termed grafting-from, or by coupling polymers containing a single reactive site at the chain end to specific amino acids on proteins, termed grafting-to. Grafting-from requires that the monomer be water soluble and compatible with the protein structure; these requirements limit the range of chemical functionality that can be incorporated into the structure. Grafting-to suffers from low coupling efficiencies due to the need for two large molecules to react at a single site. In both approaches, new polymer structures must be synthesized each time new bioconjugate structures are desired. This NSF project seeks to directly address these limitations by investigating side-chain reactive polymers for the modular and combinatorial synthesis of protein-polymer conjugates. The proposed work will use a post-polymerization modification strategy to synthesize hydrophilic, side-chain reactive polymers that can be efficiently conjugated to proteins through either amine-activated ester or thiol-maleimide reactions. Side-chain and chain-end reactive polymers will be directly compared to establish side-chain reactive polymers as an alternative to terminally reactive polymers. Side-chain reactive polycarbonates will also be explored for the synthesis of degradable protein-polymer conjugates. The work proposed here will demonstrate efficient, combinatorial routes for protein-polymer-drug conjugate synthesis as well as contribute to the collective understanding of how macromolecular structure influences the function of protein-polymer conjugates.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.